Clinical Trials
3 trialsNCT01140360 2017-07-02
0908-09
Indiana University
Phase 1/2 Completed
NCT01673009 2016-04-06
Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Indiana University
Phase 2 Completed
NCT00427583 2012-08-07
Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
Novartis
Phase 2/3 Terminated